North Ridge Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
North Ridge Wealth Advisors's BMY Position: Q1 2026 in Review
North Ridge Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 530 shares worth $32.1K. The position accounts for 0.02% of the portfolio, ranked #98.
North Ridge Wealth Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $32.3K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- North Ridge Wealth Advisors held 530 shares of Bristol-Myers Squibb worth $32.1K as of Q1 2026.
- North Ridge Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.02% of North Ridge Wealth Advisors's portfolio in Q1 2026, its #98 holding.
- North Ridge Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- North Ridge Wealth Advisors's Bristol-Myers Squibb position peaked at $32.3K in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on North Ridge Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.